UK small-cap RNS · 26 Oct 2026
Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.
| Time | Company | Mcap ↕ | Type | Announcement | |
|---|---|---|---|---|---|
| 09:03 | Corero Network Security CNS | £77m | Insider conviction | Director/PDMR Shareholding | |
| 07:01 | CLS Holdings CLI | £189m | Not yet sorted | Expected Exit from UK REIT Regime
Notice of expected exit from the UK Real Estate Investment Trust (REIT) Regime |
|
| 07:00 | Pensana PRE | £129m | Project milestones | Update on financing and mine development
The Company has continued its discussions with major shareholders, Cascade and others for the investment of the equity required by subsidiary Ozango Minerais sa (Ozango) with a view to bring the Longonjo mine (Longonjo) through commissioning in early 2028 and … |
|
| 07:00 | Auction Technology Group ATG | £580m | Activist campaign | 2.8 Announcement
for and on behalf of funds and/or investment vehicles managed or advised by it ("FitzWalter") |
|
| 07:00 | Auction Technology Group ATG | £580m | Activist campaign | Members' Statement
Vote FOR the Resolutions at the forthcoming General Meeting |
|
| 07:00 | PureTech Health PRTC | £268m | Project milestones | PRTC's Gallop Presents Ph1b LYT-200 Data at ESMO
PureTech Presents Phase 1b Results for LYT-200 in Relapsed/Refractory (R/R) High-Risk Myelodysplastic Syndromes (HR-MDS) and Acute Myeloid Leukemia (AML) at ESMO 2026 |
|
| 07:00 | HUTCHMED (China) Limited HCM | £1,877m | Project milestones | SAFFRON Phase III Data ESMO & NEJM Publication
- ORPATHYS® plus TAGRISSO® reduced the risk of disease progression or death by 45% and the risk of death by 32% in MET-driven EGFR-mutated lung cancer after progression on TAGRISSO® - |
|
| 07:00 | Cobra Resources COBR | £35m | Project milestones | Maiden Rare Earth Mineral Resource Estimate
150 Mt MRE with significant growth potential to underpin Wudinna Rare Earth Scoping Study |
|
| 07:00 | Blencowe Resources BRES | £31m | Project milestones | Graphite Outcrops Across 25km of Strike
Graphite Found at Surface Across c.25km of Strike at Orom-Cross, with +20% TGC at Three Targets |
|
| 07:00 | Eagle Eye Solutions Group EYE | £137m | Capital return | Launch of Share Buyback Programme
Eagle Eye, an AI-powered loyalty and promotions platform enabling the world's leading consumer facing brands to deliver true personalised customer engagement at scale, announces that from today, the Company will commence a share buyback programme to … |
|
| 07:00 | Nativo Resources NTVO | £4.0m | Project milestones | Design and Construction Engineering Contract
Award of Detailed Design and Construction Engineering Contract |
|
| 07:00 | Sareum Holdings SAR | £38m | Dilutive fundraise | Fundraise, Retail Offer and AIM Restoration
Subscription to raise approximately £3.2 million, intention to launch WRAP Retail Offer and restoration of trading on AIM |
|
| 07:00 | Bluebird Merchant Ventures BMV | £1.2m | Capital return | Commencement of Share Buyback Programme
Further to the announcement of 19 October 2026, Bluebird Mining Ventures Ltd (LSE: BMV) ("Bluebird", "BMV" or the "Company") is pleased to announce the commencement of its share buyback programme (the "Programme") under which the Company intends to acquire … |
|
| 07:00 | Empyrean Energy EME | £3.5m | Project milestones | Update on GOLD Project
Empyrean Energy PLC / Index: AIM / Epic: EME / Sector: Oil & Gas |
|
| 07:00 | Atlantic Lithium Limited ALL | £111m | Project milestones | Completion of Novation Agreement
Zhejiang Huayou Cobalt Co., Limited Acquires Ewoyaa Rights and Obligations from Elevra Lithium Limited |
|
| 07:00 | 88 Energy Limited 88E | £15m | Project milestones | Quarterly Report and Appendix 5B
88 Energy Limited (ASX: 88E, AIM: 88E, OTC: EEENF) (88 Energy, 88E or the Company) provides the following report on its activities for the quarter ended 30 September 2026. |
|
| 07:00 | Big Technologies BIG | £268m | Legal & regulatory | Further Litigation Update
(“Big Technologies” or the “Company” and, together with its subsidiaries the “Group”) |
|
| 07:00 | Avacta Group AVCT | £277m | Project milestones | PFS Nearly Doubles with Faridoxorubicin Treatment
Faridoxorubicin Treatment Results in Near Doubling of Progression-Free Survival and Clinically Meaningful Tumor Shrinkage in Most Patients with Salivary Gland Cancers |
|
| 07:00 | Rome Resources RMR | £16m | Project milestones | New Brunswick Project Update
New Brunswick Project Update: 2.6km Tin-Bearing Breccia Trend Identified Within Mount Pleasant Caldera |
|
| 07:00 | NeoTerra Group TERA | £6.4m | Not yet sorted | Monte Muambe Interest Increase to 70%
NeoTerra Group Plc (LSE: TERA) (OTCQB: ANRCF), the African critical minerals exploration and development company, is pleased to announce the completion of Phase 3 of the Farm-Out Agreement dated 23 June 2021, NeoTerra having met the minimum expenditure … |
|
| 07:00 | Angus Energy ANGS | £15m | Project milestones | Third Quarter 2026 Update
(“Angus Energy”, the “Company” or together with its subsidiaries, the “Group”) |
|
| 07:00 | Cizzle Biotechnology Holdings CIZ | £4.4m | Dilutive fundraise | £500,000 Subscription, conversion of loan notes
Cizzle Biotechnology, the UK based diagnostics developer of early cancer tests, announces that it has conditionally raised £500,000, before expenses, by way of direct subscription (“Subscription”) by Frazer Lang, an existing shareholder of the Company (the … |
|
| 07:00 | Safestay SSTY | £5.5m | Balance-sheet stress / refinancing | Trading Update
Safestay plc (AIM: SSTY), one of Europe's largest hostel groups, provides the following trading update. |
|
| 07:00 | Critical Metals CRTM | £83m | New CEO / reset | Final Results
LONDON, 26 October 2026 – Critical Metals plc (LSE: CRTM), a mining company established to acquire mining opportunities in the critical and strategic metals sector, currently developing the Molulu Copper/Cobalt Project (“Molulu”) in the Democratic Republic of … |
|
| 07:00 | Bioventix BVXP | £104m | Upgrade / downgrade cycle | Results for the year ended 30 June 2026
Bioventix plc (BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, announces its audited results for the year ended 30 June 2026. |
|
| 07:00 | One Health Group PLC OHGR | £40m | Project milestones | Trading Update
H1 27 Revenue and EBITDA significantly ahead of prior year |
|
| 07:00 | Orosur Mining Inc OMI | £58m | Project milestones | Results for First Quarter ended August 31, 2026
(“Orosur” or “the Company”) (TSX-V: OMI) (AIM: OMI) announces its unaudited results for the first quarter ended August 31, 2026. |
|
| 07:00 | River Global Plc RVRB | £8.6m | Cash shell / net cash above market value | Company Update
River Global PLC ("River Global" or the "Company") |